Globo H-KLH (OPT-822/821)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Globo H-KLH (OPT-822/821), covering 2014-05-07 to 2014-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer [Phase 2]